Package 71288-109-20

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 71288-109-20
Digits Only 7128810920
Product NDC 71288-109
Product ID 71288-109_695b376b-3972-4aef-b003-f1fb6fcde5b7
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (71288-109-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2018-07-17
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "695b376b-3972-4aef-b003-f1fb6fcde5b7", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["249364"], "spl_set_id": ["8105e590-fc7e-45b7-9604-c2d0d1be5eac"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (71288-109-20)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "71288-109-20", "marketing_start_date": "20180717"}], "brand_name": "Cytarabine", "product_id": "71288-109_695b376b-3972-4aef-b003-f1fb6fcde5b7", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-109", "generic_name": "Cytarabine", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "2 g/20mL"}], "application_number": "ANDA205696", "marketing_category": "ANDA", "marketing_start_date": "20180717", "listing_expiration_date": "20261231"}